The range of autoimmune diseases treatable with chimeric antigen receptor (CAR) T-cell therapy could be much broader than ...

The back of the 15T Pro is home to a triple-camera array, which includes a 50-megapixel main camera, a 50-megapixel telephoto ...

New research by the IU School of Medicine is looking at new ways to fight aggressive cancers. Right now the focus is on ...

Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in ...

A California dad with leukemia says his 10-year-old son is his hero after the boy donated stem cells to his father.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

The study evaluated lifileucel in patients 18 years and older with unresectable or metastatic melanoma (stage IIIc or IV) who ...

Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy.

The amount of any given protein in a cell has to be controlled to keep its levels within a range required for healthy ...

Approximately 60% to 70% of patients aged 18 to 65 years will achieve a complete remission, but just 30.5% of these patients ...